You are here
NATURAL PHARMACIA INTERNATIONAL, INC.
UEI: S1XLM7VGK1W6
# of Employees: 8
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: Yes
Award Charts
Award Listing
-
Preclinical Validation of Novel High Affinity D2 Receptor Agonists for PET Neuroimaging
Amount: $999,145.00PROJECT SUMMARY The goal of this project is to develop commercialF PET radiopharmaceuticals for evaluating the proportion of Dreceptors in the high affinity state in human diseasesincluding Parkinson ...
SBIRPhase II2017Department of Health and Human Services National Institutes of Health -
Development of Alkontrol herbal for Treating Alcohol Abuse
Amount: $1,000,000.00This application for a Fast Track STTR award represents a collaboration between Natural Pharmacia InternationalIncNPIand McLean Hospital to initiate steps toward commercializing a isoflavone botanical ...
STTRPhase II2017Department of Health and Human Services National Institutes of Health -
Development of Alkontrol herbal for Treating Alcohol Abuse
Amount: $154,747.00DESCRIPTION provided by applicant This application for a Fast Track STTR award represents a collaboration between Natural Pharmacia International Inc NPI and McLean Hospital to initiate steps t ...
STTRPhase I2016Department of Health and Human Services National Institutes of Health -
Development of a Tritiated Agonist Radioligand for the D2 Receptor
Amount: $148,426.00DESCRIPTION (provided by applicant): The goal of this project is to develop a novel agonist radioligand for evaluating the proportion of D2 receptors in the high state. The D2high receptor is thought ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
Development of Puerarin to Reduce Alcohol Drinking
Amount: $2,999,450.00DESCRIPTION (provided by applicant): This application is a resubmission in response to AA-04-002 from the National Institute on Alcohol Abuse and Alcoholism to continue our STTR (Phase I and II) study ...
SBIRPhase II2006Department of Health and Human Services National Institutes of Health -
Oral Pimonidazole
Amount: $111,879.00DESCRIPTION (provided by applicant): The patented Hypoxyprobe TM system for measuring tissue hypoxia has been licensed for use in experimental animals. In addition, an FDA IND is available for the cli ...
STTRPhase I2004Department of Health and Human Services National Institutes of Health -
Oral Pimonidazole
Amount: $111,879.00DESCRIPTION (provided by applicant): The patented Hypoxyprobe TM system for measuring tissue hypoxia has been licensed for use in experimental animals. In addition, an FDA IND is available for the cli ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
Naturally Occurring Agent for Alcohol Liver Diseases
Amount: $222,677.00DESCRIPTION (provided by applicant): Chronic heavy ethanol consumption has major adverse effects on the mammalian liver, namely the induction of hepatocellular damage and impairment of regeneration f ...
STTRPhase I2003Department of Health and Human Services National Institutes of Health -
DEVELOPMENT OF STANDARDIZED MILK THISTLE PRODUCT
Amount: $1,048,275.00DESCRIPTION (Provided by applicant): The objective of this Phase I and II fast track application is to develop a standardized milk thistle product and to assure a quality controlled and reliable sourc ...
STTRPhase II2002Department of Health and Human Services National Institutes of Health -
DEVELOPMENT OF STANDARDIZED MILK THISTLE PRODUCT
Amount: $0.00DESCRIPTION (Provided by applicant): The objective of this Phase I and II fast track application is to develop a standardized milk thistle product and to assure a quality controlled and reliable sourc ...
STTRPhase I2002Department of Health and Human Services National Institutes of Health
